AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05009433 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High intensity interval training program for nonpregnant women
Description: Nonpregnant women will participate in 8-week HIIT cycles for a period of 8 months, 3 times a week, in a volume of each session of 60 minutes. The main part (15-20 min) will be conducted in a form of high intensity intervals, approx. 85-90% of maximum exercise capacity. The intervals will consist of performing exercises for 30-60 seconds, alternating with a 30-60 second rest break, in the ratio of exercise time to rest 1:2, 1:1 or 2:1, according to the individual possibilities of the participant and taking into account the training progression. The exercise intensity will be monitored with the use of heart rate monitors, the Borg Rating of Perceived Exertion (RPE) and the Talk Test.~For the next 12 months of the project, women will participate in 3-month HIIT cycles. Classes will be carried out stationary or online, depending on the pandemic situation and the availability of the woman.
Study NCT05009433 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Moderate intensity continuous training program for nonpregnant women
Description: Nonpregnant women will participate in 8-week MICT cycles for a period of 8 months, 3 times a week, in a volume of each session of 60 minutes. The main part (20-25 min) will be conducted in a form of moderate continuous intensity exercise, of 70-80% of the maximum exercise capacity, e.g. in the form of high- and low-impact aerobics choreography with music. The sessions will also include resistance, neuromotor, body posture and flexibility exercises (25 min), breathing exercises and relaxation (10 min). The exercise intensity will be monitored with the use of heart rate monitors, the Borg Rating of Perceived Exertion (RPE) and the Talk Test.~For the next 12 months of the project, women will participate in 3-month MICT cycles. Classes will be carried out stationary or online, depending on the pandemic situation and the availability of the woman.
Study NCT05009433 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Standard health care with extended education on healthy lifestyle
Description: Nonpregnant women will get standard health care according to the national law. They will attend educational sessions on a healthy lifestyle, physical activity and selected aspects of preparation to pregnancy and motherhood. Classes will be conducted online in real time, at least once every two weeks, for a period of 20 months.
Study NCT05172479 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of qSOFA score
Description: At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's qSOFA score.
Study NCT05172479 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of SIRS criteria
Description: At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's SIRS criteria.
Study NCT05172479 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of NEWS
Description: At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's NEWS.
Study NCT05172479 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of NEWS2
Description: At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's NEWS2.
Study NCT05172479 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of MEWS
Description: At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's MEWS.
Study NCT06107179 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multispectral Optoacoustic Tomography
Description: In MSOT, laser light is emitted into the target tissue via a handheld probe. Thermoelastic expansion of various molecules in the target area generates ultrasound waves that are detected by the transducer. The detected signals are reconstructed into images using algorithms. Spectral analysis of the optoacoustic signal at different wavelengths in the near-infrared range can detect individual chromophores, such as oxygenated and deoxygenated hemoglobin.
Study NCT05130671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard of care
Description: Standard of care treatment as per the hospital guidelines
Study NCT05130671 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard of care treatment as per the hospital guidelines
Study NCT05130671 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Investigational treatment
Description: Combination of quercetin and curcumin as add-on to the standard of care
Study NCT06246383 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Q Actin
Description: cucumber extract
Study NCT06246383 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Q Actin
Description: cucumber extract
Study NCT01006343 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Higher Protein (HP)
Study NCT01006343 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lower Protein (LP)
Study NCT06325449 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STREAM program
Description: The STREAM program is a 24-week weight-loss program which includes meal replacement, dietician coaching/teaching and weekly visits with a physician.
Study NCT06258525 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Standard of care oxaliplatin-based chemotherapy
Description: mFOLFOX6 or CAPOX
Study NCT06258525 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: S-adenosylmethionine (SAMe) supplement
Description: (400 mg tablet): 2 tablets taken orally AM and 1 tablet PM daily (total 1,200 mg daily) prior to surgical resection
Study NCT04374448 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Sinonasal Benign or Malignant Tumor Resection
Description: During sinus tumor resection, margins will initially be estimated with the naked eye. Then the dye, Indocyanine Green (ICG), will be injected through the intravenous line to identify tumor margins and be compared to estimated margins.
Study NCT04374448 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Skull Base Surgery (Assessment of Nasoseptal Flap)
Description: In this surgery, a piece of individuals septum will be used for the reconstruction. The amount of time for the flap to fluoresce Indocyanine Green (ICG) will be measured. It will be ensured that the it is still lighting up at the end of the surgery, indicating it is still receiving a good supply and ensures longevity of the flap.
Study NCT04374448 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Endoscopic Sinus Surgery
Description: During the surgery, the timing of Indocyanine Green (ICG) administration to fluorescence of anterior and posterior ethmoidal artery and of the internal carotid artery will be measured.
Study NCT04374448 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Posterior Epistaxis Management (SPA Ligation)
Description: During surgery timing of Indocyanin Green (ICG) administration to fluorescence of the sphenopalatine artery will be measured.
Study NCT05910853 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Specimen Donation
Description: Blood donation
Study NCT04904120 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: [203Pb]VMT01
Description: Diagnostic imaging radiopharmaceutical; by intravenous infusion
Study NCT04904120 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: [68Ga]VMT02
Description: Diagnostic imaging radiopharmaceutical; by intravenous infusion
Study NCT06414564 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic 780G insulin pump
Description: Subjects on insulin infusion by 780G AHCL system
Study NCT05234502 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adequate and balanced healthy diet program (CHO: 45-60%, protein:10-20%, fat:20-35%)
Description: In calculating the estimated basal metabolic rate of individuals, Mifflin-St. The Jeor Equation will be used.BMR will be multiplied by the physical activity factor of the individual and 500\*700 kcal will be subtracted from the found value and the total daily energy requirement will be obtained.
Study NCT05234502 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Adequate and balanced healthy diet program (CHO: 45-60%, protein:10-20%, fat:20-35%)
Description: In calculating the estimated basal metabolic rate of individuals, Mifflin-St. The Jeor Equation will be used.BMR will be multiplied by the physical activity factor of the individual and 500\*700 kcal will be subtracted from the found value and the total daily energy requirement will be obtained.
Study NCT05234502 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic diet program (CHO: 6%, protein:19%, fat:75%)
Description: A ketogenic diet will be applied to Group 1 for 12 weeks simultaneously with taxane treatment.
Study NCT04818892 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serological Assay for SARS-CoV-2
Description: LabCorp's Cov2Quant IgG™ assay which uses immunoassay that uses electrochemiluminescent technology (ECL) for quantitative determination of anti-receptor binding domain (RBD) IgG antibodies specific to SARS-CoV-2.
Study NCT05166876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brequinar Sodium
Description: 50 mg, 100 mg, 150 mg, 200 mg x 5 days
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone 10mg administered via IV once postoperatively within 24 hours for pain and swelling
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Dexamethasone 10mg administered via IV once postoperatively within 24 hours for pain and swelling
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: 1,000mg administered via tablet every 8 hours for pain during the first 1-2 weeks postoperatively
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: 1,000mg administered via tablet every 8 hours for pain during the first 1-2 weeks postoperatively
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lyrica
Description: Administered via tablet 75mg nightly for pain during the first 1-2 weeks postoperatively
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lyrica
Description: Administered via tablet 75mg nightly for pain during the first 1-2 weeks postoperatively
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celebrex
Description: 200mg administered via tablet twice a day for pain and swelling during the first 1-2 weeks postoperatively
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Celebrex
Description: 200mg administered via tablet twice a day for pain and swelling during the first 1-2 weeks postoperatively
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meloxicam
Description: 30mg administered via IV once postoperatively within 24 hours for pain and swelling
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meloxicam
Description: 30mg administered via IV once postoperatively within 24 hours for pain and swelling
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone
Description: 5mg administered via tablet every 4 hours as needed for pain during the first 1-2 weeks postoperatively
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone
Description: 5mg administered via tablet every 4 hours as needed for pain during the first 1-2 weeks postoperatively
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: 20 milliliters Ropivacaine 0.2% administered via injection perioperatively.
Study NCT05974501 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 20 milliliters Ropivacaine 0.2% administered via injection perioperatively.
Study NCT05770674 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1 Month vs. 12 Months DAPT
Description: Dual antiplatelet therapy with aspirin plus clopidogrel will be given for the following period after PCI according to patient allocation~1. 1 Month following PCI, followed by clopidogrel monotherapy~2. 12 Months following PCI
Study NCT04842032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KRN23
Description: KRN23 is a sterile clear colourless and preservative free solution supplied in single use 5 mL vials containing 1 mL of KRN23 at a concentration of 30mg/mL
Study NCT05062993 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: caudal epidural pulse radio frequency
Description: A needle is inserted into the caudal epidural space under ultrasound guidance and pulse radiofrequency is administered at 5 Hz using a 5. ms pulse width for 600 seconds at 55 V.
Study NCT04841473 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TRAIN Concussion Education
Description: Participants will receive the TRAIN concussion education module.
Study NCT04841473 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Concussion Education
Description: Participants will receive a standard concussion education module.
Study NCT05566483 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: exercise protocol
Study NCT05608928 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: VSL#3
Description: VSL#3 is a commercial probiotic mixture consisting of eight probiotic lactic acid bacteria and Bifidobacteria including Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus delbrueckii subspecies bulgaricus, Streptococcus salivarius subspecies thermophiles, Bifidobacterium breve, Bifidobacterium longum, and Bifidobacterium infantis. VSL#3 contributes to balancing the gut and vaginal microbiota and is used as a food supplement for management of diseases like irritable bowel syndrome, ulcerative colitis or ileal pouch.
Study NCT05608928 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Capscan device
Description: The CapScan device is a short-term single-use class IIa ingestible medical device that collects fluids from the gastrointestinal (GI) tract and is collected in the stool. GI samples are then extracted from the device and analyzed outside the body.
Study NCT06258525 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: At 1-Month
Study NCT05820893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Resistant Potato Starch
Description: MSPrebiotic (MSPrebiotic Inc, Carberry, Manitoba, Canada). MSPrebiotic is an unmodified resistant starch derived from potatoes (Solanar tuberosum). It consists of 20% amylose and 80% amylopectin forming granules the stomach and small intestine are unable to digest allowing for absorption in the colon. MSPrebiotic is consumed by mixing 10g into cold or room temperature foods or beverages; it is not to be heated. Participants will be instructed to take MSPrebiotic 2 or more hours before or after consuming any medications.
Study NCT05608928 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: microcrystalline cellulose
Study NCT05166876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dipyridamole 75 MG
Description: 75 mg TID for 5 days
Study NCT05166876 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 50 mg, 100 mg, 150 mg, 200 mg x 5 days
Study NCT06118918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phase II comprehensive cardiac rehabilitation program
Description: the program extends over 3 months after cardiac surgery. The program includes exercise, health education, and stress management. all content will be delivered to the participants through the WhatsApp application as instruction videos and short lectures. exercise will be gradually increased in terms of intensity, and duration. health education will cover topics like a healthy diet blood pressure, blood cholesterol control, smoking cessation ...etc. stress management will include relaxation therapy, breathing control, behavioral change, and other strategies to control stress. Phone call follow-ups once weekly will be made by one of the research team to evaluate the adherence and answer potential questions All interventions are guided by universal guidelines like the Australian Cardiovascular Health and Rehabilitation Association (ACRA) and American Heart Association (AHA
Study NCT02431221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Perhexiline
Description: perhexiline maleate, oral, 25mg or 100mg tablets Whenever initiating PHM therapy, subjects will receive a loading regimen of PHM as indicated in in the Heart Metabolics Dose Justification document. Drug levels will be measured first on Day 4 +/- 1 day, with an initial dose adjustment performed on Day 7 +/- 1 day, as needed. The next sampling will occur on Day 21 +/- 1 day for potential dose adjustment, as advised by the DCC, on or about Day 24. Subsequent dosing will be monitored and advised by a Dose Control Center
Study NCT02431221 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05703932 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: home-based exercises
Description: Joint range of motion and stretching exercises for cervical, thoracic and lumbar spine, stretching for erector spina, hamstring and shoulder muscles, chest expansion, abdominal and diaphragmatic breathing exercises will be applied. Exercises will be performed at submaximal level, paying attention to blood pressure, arterial (TA) and heart rate.For the patients in the exercise group, it was planned to perform the exercise program 5 days a week in 1 set with 10 repetitions, 40 minutes/day.
Study NCT06562777 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-Interventional Study
Study NCT05241691 — intervention group
Intervention type: DEVICE
Intervention: Guided Growth Plate System Plus
Description: The implant is thought as one of the surgical options to perform epiphysiodesis and hemiepiphysiodesis minimally invasive, that is without recourse to a corrective osteotomy.
Study NCT05076253 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin
Description: Ivermectin plus standard care
Study NCT05076253 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ivermectin
Description: Ivermectin plus standard care
Study NCT05076253 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Standard care
Study NCT05076253 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Standard care
Study NCT05704127 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intelligent Moxibustion Robot
Description: The intelligent moxibustion robot holds the thunder fire moxibustion stick and conducts suspension moxibustion treatment on the points BL23, BL25, DU3 and pain points for 10 minutes in each group, a total of 40 minutes. BL23 and BL25 have one acupuncture point on each side of the spine, and the straight line reciprocating moxibustion technique is adopted. DU3, a single point, adopts the whirling moxibustion technique. Pain points,according to the number of pain points, choose straight reciprocating moxibustion or rotary moxibustion.
Study NCT05704127 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Artificial moxibustion
Description: The people hold the thunder fire moxibustion stick and conducts suspension moxibustion treatment on the points BL23, BL25, DU3 and pain points for 10 minutes in each group, a total of 40 minutes. BL23 and BL25 have one acupuncture point on each side of the spine, and the straight line reciprocating moxibustion technique is adopted. DU3, a single point, adopts the whirling moxibustion technique. Pain points,according to the number of pain points, choose straight reciprocating moxibustion or rotary moxibustion.
Study NCT05997394 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A prayer concert will be held for the participants.
Description: Participants who are in the experimental group will be given a prayer audience.
Study NCT04970953 — intervention group
Intervention type: PROCEDURE
Intervention: Right heart catheterization
Description: Right heart catheterization will be performed via a brachial access under sonographic guidance and hemodynamic measurements will be performed in a semi-supine position.
Study NCT04998136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide 2.4 mg
Description: Administered subcutaneously (s.c., under the skin) as well as reduced-calorie diet and increased physical activity for 44 weeks. Doses gradually increased to 2.4 mg
Study NCT04998136 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (semaglutide 2.4 mg)
Description: Administered s.c. as well as reduced-calorie diet and increased physical activity for 44 weeks
Study NCT04422275 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Budesonide
Description: The drug intervention budesonide (0.5 mg /capsule) will be dissolved in 240 ml nasal saline lavage.
Study NCT04422275 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: High-Concentration Essential Oil
Description: High-concentration essential oil will include 1 ml of essential oil per jar.
Study NCT04422275 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: The placebo (lactose monohydrate) drug will be dissolved in 240 ml of nasal saline lavage.